1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Greece Pharmaceuticals and Healthcare Report Q4 2016

Greece Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 88 pages

Includes 3 FREE quarterly updates



BMI View:
The government's focus on increasing the consumption of generic medicines and poor financialadministration highlights Greece as a challenging market for innovative drugmakers. Despite an urgentneed to reduce pharmaceutical and healthcare spending, enduring public scepticism of generic medicineswill prevent targeted reduction in patented drug usage. Moreover, dissatisfaction among the public andprofessionals over staff shortages, poor wages and pension reform within the healthcare sector, coupledwith corruption issues and the ongoing migrant influx, signify an unhealthy outlook.

Headline Expenditure Projections


- Pharmaceuticals: EUR4.95bn (USD5.48bn) in 2015 to EUR5.00bn (USD5.35bn) in 2015, 1.0% in localcurrency terms and -2.5% in US dollar terms. Forecast upgraded from previous quarter.

- Healthcare: EUR13.90bn (USD15.41bn) in 2015 to EUR14.02bn (USD15.00bn) in 2016, 0.9% in localcurrency terms and -2.6% in US dollar terms. Forecast upgraded from previous quarter.

Table Of Contents

Greece Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Greece 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Greece 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2012-2020) 19
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2012-2020) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Greece 2012-2020) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Greece 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Greece 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Greece 2012-2020) 26
OTC Drug Market Forecast 27
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Greece 2012-2020) 29
Pharmaceutical Trade Forecast 30
Table: Pharmaceutical Trade Data And Forecasts (Greece 2014-2020) 32
Table: Pharmaceutical Trade Data And Forecasts local currency (Greece 2014-2020) 32
Industry Risk/Reward Index 33
Central And Eastern Europe Risk/Reward Index - Q4 2016 33
Greece Risk/Reward Index 40
Rewards 40
Risks 41
Regulatory Review 42
Intellectual Property Issues 44
Pricing Regime 45
Reimbursement Regime 47
Market Overview 49
Healthcare Sector 49
Table: Healthcare Resources (Greece 2010-2015) 53
Table: Healthcare Personnel (Greece 2010-2015) 53
Table: Healthcare Activity (Greece 2010-2015) 54
Healthcare Insurance 54
Research and Development 55
Clinical Trials 55
Epidemiology 56
Competitive Landscape 59
Research-Based Industry 59
Table: Multinational Market Activity 61
Pharmaceutical Distribution 63
Pharmaceutical Retail Sector 63
Company Profile 65
Elpen 65
Genesis Pharma 67
Kleva 69
Lavipharm 70
Pharmathen 72
Vianex 75
Demographic Data 77
Demographic Forecast 77
Table: Population Headline Indicators (Greece 1990-2025) 78
Table: Key Population Ratios (Greece 1990-2025) 78
Table: Urban/Rural Population and Life Expectancy (Greece 1990-2025) 79
Table: Population By Age Group (Greece 1990-2025) 79
Table: Population By Age Group % (Greece 1990-2025) 80
Glossary 82
Methodology 84
Pharmaceutical Expenditure Forecast Model 84
Healthcare Expenditure Forecast Model 84
Notes On Methodology 85
Risk/Reward Index Methodology 86
Index Overview 87
Table: Pharmaceutical Risk/Reward Index Indicators 87
Indicator Weightings 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.